WDTN

PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

Significant Advances in SMRT Cell Design, Compute, and a New System Architecture Will Enable Revio to Dramatically Increase Throughput and Lower Cost While Leveraging the Power of HiFi for Exceptional ...
Nasdaq

PacBio’s HiFi Sequencing Technology Shows Promising Results for Rare Disease Diagnostics in Collaboration with Radboud University Medical Center

PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...
Nasdaq

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
Seeking Alpha

PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project

MENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi ...